| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rallybio Corp | Director | Option (Right to Buy) | 16,500 | $29,205 | $1.77 | 15 May 2024 | Direct |
| Prime Medicine, Inc. | Director | Stock Option (right to buy) | 45,000 | 01 Aug 2025 | Direct | ||
| Rallybio Corp | Director | Option (Right to Buy) | 28,500 | 13 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | 01 Aug 2025 | 8 | $0 | 4 | Director | 05 Aug 2025, 20:43 |
| PRME | Prime Medicine, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 18:13 |
| RLYB | Rallybio Corp | 13 May 2025 | 1 | $0 | 4 | Director | 15 May 2025, 17:09 |
| PRME | Prime Medicine, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:58 |
| RLYB | Rallybio Corp | 15 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 17:03 |
| PRME | Prime Medicine, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 17:47 |
| RLYB | Rallybio Corp | 17 May 2023 | 1 | $0 | 4 | Director | 19 May 2023, 17:19 |
| RLYB | Rallybio Corp | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 17:27 |
| PRME | Prime Medicine, Inc. | 19 Oct 2022 | 1 | $0 | 4 | Director | 21 Oct 2022, 16:31 |
| PRME | Prime Medicine, Inc. | 19 Oct 2022 | 0 | $0 | 3 | Director | 19 Oct 2022, 20:04 |
| RLYB | Rallybio Corp | 01 Aug 2022 | 1 | $0 | 4 | Director | 03 Aug 2022, 17:48 |
| RLYB | Rallybio Corp | 01 Aug 2022 | 0 | $0 | 3 | Director | 03 Aug 2022, 17:38 |